The US FDA has granted orphan drug designation to Shanghai-headquartered biotech CARsgen Therapeutics' CAR-T cell therapy CT053 for multiple myeloma…

Professor James Chim, chairman and founder of the Hong Kong Society of Myeloma, shares the history and key objectives of the organization. He also…

Pasquale Frega, General Manager for Celgene Italy, discusses the company’s rapid growth and imminent entry into immunology, the business and…

Anita Atema, General Manager of Celgene, reveals Celgene’s inspiring and concrete  initiatives that illustrate how a true willingness to cooperate…